The impact of patient preference in the treatment algorithm for recurrent/metastatic head and neck squamous cell carcinoma

The advent of immune checkpoint inhibitors for recurrent/metastatic head and neck squamous cell carcinoma (RM-HNSCC) has revolutionized the standard of care approach in first-line treatment. The heterogeneity of disease presentation and treatment-related toxicities can be associated with suboptimal...

Descripción completa

Detalles Bibliográficos
Autores principales: Salvestrini, Viola, Becherini, Carlotta, Desideri, Isacco, Caprara, Luisa, Mariotti, Matteo, Banini, Marco, Pierossi, Nicola, Scotti, Vieri, Livi, Lorenzo, Bonomo, Pierluigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2022
Materias:
Computed Tomography
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349154/
https://www.ncbi.nlm.nih.gov/pubmed/35752659
http://dx.doi.org/10.1007/s11547-022-01509-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349154/
https://www.ncbi.nlm.nih.gov/pubmed/35752659
http://dx.doi.org/10.1007/s11547-022-01509-1

Ejemplares similares